- Home
- LPSN vs PLRX Comparison
LPSN vs PLRX Comparison
Compare LPSN & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPSN
- PLRX
- Stock Information
- Founded
- LPSN 1995
- PLRX 2015
- Country
- LPSN United States
- PLRX United States
- Employees
- LPSN N/A
- PLRX N/A
- Industry
- LPSN EDP Services
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- LPSN Technology
- PLRX Health Care
- Exchange
- LPSN Nasdaq
- PLRX Nasdaq
- Market Cap
- LPSN 84.5M
- PLRX 93.3M
- IPO Year
- LPSN 2000
- PLRX 2020
- Fundamental
- Price
- LPSN $0.54
- PLRX $1.51
- Analyst Decision
- LPSN Hold
- PLRX Hold
- Analyst Count
- LPSN 1
- PLRX 10
- Target Price
- LPSN N/A
- PLRX $3.93
- AVG Volume (30 Days)
- LPSN 5.8M
- PLRX 394.6K
- Earning Date
- LPSN 11-06-2025
- PLRX 11-06-2025
- Dividend Yield
- LPSN N/A
- PLRX N/A
- EPS Growth
- LPSN N/A
- PLRX N/A
- EPS
- LPSN N/A
- PLRX N/A
- Revenue
- LPSN $271,750,000.00
- PLRX N/A
- Revenue This Year
- LPSN N/A
- PLRX N/A
- Revenue Next Year
- LPSN N/A
- PLRX N/A
- P/E Ratio
- LPSN N/A
- PLRX N/A
- Revenue Growth
- LPSN N/A
- PLRX N/A
- 52 Week Low
- LPSN $0.50
- PLRX $1.10
- 52 Week High
- LPSN $2.08
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- LPSN 31.20
- PLRX 48.98
- Support Level
- LPSN $0.52
- PLRX $1.46
- Resistance Level
- LPSN $0.60
- PLRX $1.55
- Average True Range (ATR)
- LPSN 0.05
- PLRX 0.07
- MACD
- LPSN -0.00
- PLRX 0.00
- Stochastic Oscillator
- LPSN 16.38
- PLRX 65.52
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.